Digitisation | April 05, 2022
Feedback Medical brings Bleepa to India
Announces pilot project for rapid, remote diagnosis of tuberculosis
Announces pilot project for rapid, remote diagnosis of tuberculosis
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
The brand Azmarda fits well with JBCPL's overall strategy of strengthening its presence in the cardiology segment in India.
Among patients with infectious virus at baseline, no patients who received Lagevrio had infectious virus at days 3, 5 or 10
The Cidmus brand shall be affixed on the pharmaceutical composition comprising a combination of Valsartan and Sacubitril (currently under Novartis patent) which is indicated for heart failure patients with reduced ejection fraction
Through this partnership, Premas will connect with genomics labs to provide automated NGS solutions
It is an application to automate statistical analysis and reporting for clinical research.
Fujifilm has been at the forefront of medical imaging and healthcare informatics. It’s developing new AI platforms to address medical challenges. Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India gives us an insight in an interview with Thomas C. Thottathil, Editor, indianpharmapost.com
The companies are now preparing to initiate a Phase 1 trial to assess the safety and immunogenicity of BLB-201 in healthy volunteers
As a partner with IRIA, the company had a significant booth presence on-ground during the conference.
Subscribe To Our Newsletter & Stay Updated
